NeuroPace, Inc. (NPCE)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about NeuroPace, Inc. (NPCE)
Go deeper and ask any question about NPCE
Company Performance
Current Price
as of Sep 13, 2024$7.43
P/E Ratio
N/A
Market Cap
$216.93M
Description
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
Metrics
Overview
- HQMountain View, CA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerNPCE
- Price$7.43+2.77%
Trading Information
- Market Cap$216.93M
- Float49.38%
- Average Daily Volume (1m)42,696
- Average Daily Volume (3m)96,105
- EPS-$1.09
Company
- Revenue$71.82M
- Rev Growth (1yr)16.63%
- Net Income-$7.51M
- Gross Margin73.40%
- EBITDA Margin-30.05%
- EBITDA-$5.79M
- EV$236.25M
- EV/Revenue3.29
- P/EN/A
- P/S2.99
Documents
SEC Filings
Earnings Calls